1. |
Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyo-pathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation, 2006, 114 (21):2232-2239.
|
2. |
Case RB, Morrow AG, Stainsby W, et al. Anomalous origin of the left coronary artery; the physiologic defect and suggested surgical treatment. Circulation, 1958, 17 (6):1062-1068.
|
3. |
Marian AJ. Contemporary treatment of hypertrophic cardiomyopathy. Tex Heart Inst J, 2009, 36 (3):194-204.
|
4. |
Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surg-ical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol, 2005, 46 (3):470-476.
|
5. |
Morrow AG, Reitz BA, Epstein SE, et al. Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation, 1975, 52 (1):88-102.
|
6. |
Minakata K, Dearani JA, Nishimura RA, et al. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg, 2004, 127 (2):481-489.
|
7. |
Maron BJ, Dearani JA, Ommen SR, et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol, 2004, 44 (10):2044-2053.
|
8. |
Ryan LP, Jackson BM, Parish LM, et al. Mitral valve tenting index for assessment of subvalvular remodeling. Ann Thorac Surg, 2007, 84 (4):1243-1249.
|
9. |
Maron BJ. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation, 2007, 116 (2):196-206.
|
10. |
Maron BJ, Estes NR, Maron MS, et al. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation, 2003, 107 (23):2872-2875.
|
11. |
Ibrahim M, Rao C, Ashrafian H, et al. Modern management of systolic anterior motion of the mitral valve. Eur J Cardiothorac Surg, 2012, 41 (6):1260-1270.
|
12. |
Cooley DA. Surgical techniques for hypertrophic left ventricular obstructive myopathy including mitral valve plication. J Card Surg, 1991, 6 (1):29-33.
|
13. |
Sherrid MV, Chaudhry FA, Swistel DG. Obstructive hypertrophic cardiomyopathy:echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg, 2003, 75 (2):620-632.
|
14. |
Jezyk D, Duda B, Jerzemowski J, et al. Positions of septal papillary muscles in human hearts. Folia Morphol (Warsz), 2010, 69 (2):101-106.
|
15. |
Rao N, Gajjar T, Desai N. Accessory mitral valve tissue:an unusual cause of congenital mitral stenosis. Interact Cardiovasc Thorac Surg, 2012, 14 (1):110-112.
|
16. |
Klues HG, Maron BJ, Dollar AL, et al. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation, 1992, 85 (5):1651-1660.
|
17. |
Vogel-Claussen J, Finn JP, Gomes AS, et al. Left ventricular papillary muscle mass:relationship to left ventricular mass and volumes by magnetic resonance imaging. J Comput Assist Tomogr, 2006, 30 (3):426-432.
|
18. |
Smedira NG, Lytle BW, Lever HM, et al. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg, 2008, 85 (1):127-133.
|